May 14, 2026
#Edmonton50
Edmonton, Alberta — Proholistic Discovery (PHD) Inc. is proud to announce that the company has been selected by Scale Up Canada as one of the #Edmonton50 Most Scalable Startups in 2026 (https://www.scaleupcanada.org/edmonton50). The #Edmonton50 initiative recognizes high-potential companies demonstrating strong innovation, scalability, and growth potential within Edmonton’s rapidly expanding technology and innovation ecosystem.
Founded in 2024, Proholistic Discovery is an Edmonton-based biotechnology company focused on revolutionizing early-stage drug development through its proprietary Inference AI-powered Drug Development Engine. The company develops advanced solutions for ADMET prediction, PBPK/PD modeling, and systems pharmacology to help improve drug candidate selection and reduce clinical development risks.
“This recognition reflects the dedication of our team and validates our mission to accelerate smarter and more efficient drug development using AI-driven scientific inference,” said Dr. Richard Chih-Yuan Tseng, President and Co-founder of Proholistic Discovery. “We are honored to be included among Edmonton’s leading scalable startups and look forward to continuing to contribute to Canada’s growing biotech and AI innovation landscape.”
Proholistic Discovery would like to thank its collaborators, partners, advisors, and supporters for their continued encouragement and contributions to the company’s growth. As the company continues to expand its capabilities and partnerships, Proholistic Discovery remains committed to advancing innovative computational technologies that support the development of safer and more effective therapeutics for patients worldwide.